During the past decade, Chang Gung Memorial Hospital conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 22 clinical trials were completed, i.e. on average, 12% percent of trials that started reached the finish line to date. In the past 5 years, 96 clinical trials started and 16 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chang Gung Memorial Hospital" #1 sponsor was "Chang Gung Memorial Hospital" with 193 trials, followed by "Janssen Research & Development, LLC" with 9 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored, "National Health Research Institutes, Taiwan" with 6 trials sponsored and "Boehringer Ingelheim" with 6 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Memorial Hospital" #1 collaborator was "National Science Council, Taiwan" with 12 trials as a collaborator, "Ministry of Science and Technology, Taiwan" with 11 trials as a collaborator, "Chang Gung Memorial Hospital" with 9 trials as a collaborator, "Incyte Corporation" with 5 trials as a collaborator and "China Medical University Hospital" with 4 trials as a collaborator. Other collaborators include 72 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Chang Gung Memorial Hospital" are "Cerebral Palsy" (12 trials), "Autism Spectrum Disorder" (9 trials), "Atopic Dermatitis" (8 trials), "Mild Cognitive Impairment" (8 trials) and "Stroke" (8 trials). Many other conditions were trialed in "Chang Gung Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Chang Gung Memorial Hospital" are "Drug" (96 trials), "Device" (35 trials), "Other" (34 trials), "Behavioral" (29 trials) and "Procedure" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "intermittent theta burst stimulation" (7 trials), "Baricitinib" (5 trials), "18F-DTBZ" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Chang Gung Memorial Hospital" are 254 trials for "All" genders, 16 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 83 active trials in "Chang Gung Memorial Hospital". 5 are not yet recruiting, 62 are recruiting, 12 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 124 completed trials in Chang Gung Memorial Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Chang Gung Memorial Hospital, 6 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 104 trials that are defined as “Not Applicable".

Chang Gung Memorial Hospital has several departments that took part in Clinical trials: "Department of Psychiatry, Chang Gung Memorial Hospital" - 3 trials, "Department of Radiology, Chang Gung Memorial Hospital" - 6 trials